Literature DB >> 12651686

The influence of induced hypothermia for hemostatic function on temperature-adjusted measurements in rabbits.

Mitsuru Shimokawa1, Katsuyasu Kitaguchi, Masahiko Kawaguchi, Takanori Sakamoto, Meiko Kakimoto, Hitoshi Furuya.   

Abstract

UNLABELLED: In hypothermic patients, a tendency to bleed may be observed even when hemostatic tests seem to be normal. Coagulation and platelet function tests are usually performed at 37 degrees C. We investigated the influence of induced hypothermia on temperature-adjusted hemostasis function testing using Sonoclot Analyzer (Sonoclot) and Thromboelastography (TEG). Anesthesia was induced and maintained with IV ketamine and fentanyl on 15 male New-Zealand White rabbits. A water blanket was used to induce hypothermia to 30 degrees C and to rewarm to 37 degrees C. Blood samples were obtained at four points: before hypothermia, at 34 degrees C, at 30 degrees C, and after rewarming. Standard coagulation tests were performed at 37 degrees C (C method), and simultaneously, real temperature hemostasis function tests (R method) were run. In Sonoclot(R), activated clotting time and time to peak increased and clot rate decreased significantly at 30 degrees C in the R method compared with those in the C method. In TEG(R), reaction time and clot formation time were prolonged and clot formation rate was diminished at 30 degrees C in the R method compared with those in the C method. Induced hypothermia delayed the coagulation cascade and reduced platelet function. During hypothermia, hemostatic measurements should be performed at real temperature to avoid overestimating patient hemostatic function based on results measured at the standard 37 degrees C. IMPLICATIONS: We investigated the influence of induced hypothermia on temperature-adjusted hemostasis function tests in rabbits using Sonoclot Analyzer and Thromboelastography. Induced hypothermia delayed the coagulation cascade and reduced platelet function. The conventional coagulation tests performed at 37 degrees C failed to detect these hypothermia-induced degradations in hemostasis performance.

Entities:  

Mesh:

Year:  2003        PMID: 12651686     DOI: 10.1213/01.ane.0000050767.86196.af

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  6 in total

1.  Adaptation of global hemostasis to therapeutic hypothermia in patients with out-of-hospital cardiac arrest: Thromboelastography study.

Authors:  Aleksander Trąbka-Zawicki; Marek Tomala; Aleksander Zeliaś; Elżbieta Paszek; Wojciech Zajdel; Ewa Stępień; Krzysztof Żmudka
Journal:  Cardiol J       Date:  2017-07-11       Impact factor: 2.737

2.  Neonatal ECMO Study of Temperature (NEST)--a randomised controlled trial.

Authors:  David J Field; Richard Firmin; Denis V Azzopardi; Frances Cowan; Edmund Juszczak; Peter Brocklehurst
Journal:  BMC Pediatr       Date:  2010-04-19       Impact factor: 2.125

3.  Effect of rest temperature on rotational thromboelastometry in New Zealand White rabbits.

Authors:  Kelsea A Studer; Andrew Hanzlicek; Nicola Di Girolamo; William Womble; Debosree Pathak; Rachel Maranville; Ian Kanda; João Brandão
Journal:  J Vet Diagn Invest       Date:  2020-11-06       Impact factor: 1.279

4.  Platelet aggregation and clot formation in comatose survivors of cardiac arrest treated with induced hypothermia and dual platelet inhibition with aspirin and ticagrelor; a prospective observational study.

Authors:  Thomas Kander; Josef Dankiewicz; Hans Friberg; Ulf Schött
Journal:  Crit Care       Date:  2014-09-30       Impact factor: 9.097

Review 5.  Effect of hypothermia on haemostasis and bleeding risk: a narrative review.

Authors:  Thomas Kander; Ulf Schött
Journal:  J Int Med Res       Date:  2019-08       Impact factor: 1.671

6.  Efficacy of enteral ticagrelor in hypothermic patients after out-of-hospital cardiac arrest.

Authors:  Lisa M Tilemann; Jan Stiepak; Thomas Zelniker; Emanuel Chorianopoulos; Evangelos Giannitsis; Hugo A Katus; Oliver J Müller; Michael Preusch
Journal:  Clin Res Cardiol       Date:  2015-10-27       Impact factor: 5.460

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.